Bradykinin inhibitor appears to shorten episodes of hereditary angioedema.(Rx)(Brief Article)

Publication: Internal Medicine News

Publication Date: 15-DEC-04

Bookmark this article Print this article Link to this article Email this article Digg It! Add to del.icio.us RSS

COPYRIGHT 2004 International Medical News Group

VIENNA -- The investigational bradykinin receptor antagonist icatibant appears to hold considerable therapeutic potential in episodes of hereditary angioedema, Konrad Bork, M.D., said at the annual meeting of the European Society for Dermatological Research.

He presented an open-label, single-center pilot study in which investigators used intravenous icatibant at 0.4...

Read the full article for free courtesy of your local library.